Clinical Trial Update: PK and PD Study of NPI-001 and Cysteamine Bitartrate [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 PK and PD study of NPI-001 in combination with cysteamine bitartrate for cystinosis, and the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystinosis

Drugs mentioned

• Cysteamine Bitartrate (cysteamine bitartrate)
• NPI-001

Snippet

Sponsor: Nacuity Pharmaceuticals, Inc. | Conditions: Cystinosis | Phase 1, Phase 2 | Status: RECRUITING